Newly established ELISA for N‐ERC/mesothelin improves diagnostic accuracy in patients with suspected pleural mesothelioma

Cancer Medicine

Tadashi Sato¹  Yohei Suzuki¹  Takanori Mori¹  Masahiro Maeda²  Masaaki Abe³  Okio Hino³ 

[1] Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan;Immuno-Biological Laboratories Co., Ltd., Fujioka, Gunma, Japan;Department of Pathology and Oncology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan

关键词: Area under the curve;    biomarker;    ELISA;    N‐ERC/mesothelin;    pleural mesothelioma;   

DOI  :  10.1002/cam4.297

来源: Wiley

【 摘 要 】

Abstract

Pleural mesothelioma is an aggressive tumor, commonly caused by exposure to asbestos. The prognosis of mesothelioma remains disappointing despite multimodal treatment. We reported previously that N-ERC/mesothelin could be a useful biomarker for the early diagnosis of pleural mesothelioma and developed an enzyme-linked immunosorbent assay (ELISA) system for its detection. However, the reproducibility of our previous 7–16 ELISA system has been revealed to be unsatisfactory. To measure N-ERC/mesothelin more precisely, we developed a new 7–20 ELISA system. The subjects of this study were patients who were referred to our department with suspected pleural mesothelioma. The current study demonstrated that the newly established 7–20 ELISA system improved the sensitivity and specificity for diagnosing pleural mesothelioma compared with the previous system. Moreover, the 7–20 ELISA system showed better reproducibility and displayed the tendency of both higher sensitivity and higher specificity in plasma than in serum. Particularly for the epithelioid type, the area under the curve (AUC) and the diagnostic accuracy of N-ERC/mesothelin were excellent; the AUC was 0.91, the sensitivity was 0.95, and the specificity was 0.76 in plasma. In conclusion, assessment of N-ERC/mesothelin with our newly established 7–20 ELISA system is clinically useful for the precise diagnosis of pleural mesothelioma.

【 授权许可】

CC BY   
© 2014 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.